A prospective study of treatment response of patients with myelofibrosis and PNH type blood cells

A prospective study of treatment response of patients with myelofibrosis and PNH type blood cells - A prospective study of treatment response of patients with myelofibrosis and PNH type blood cells

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045859

Enrollment

100

Registered

2021-10-25

Start date

2020-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myelofibrosis

Interventions

blood test to detect PNH-type cells

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Myelofibrosis patient over 20 years old

Exclusion criteria

Exclusion criteria: Not appropriate to this study judged by investigator or related

Design outcomes

Primary

Measure	Time frame
Identify the MF patients with PNH-type cells	—

Secondary

Measure	Time frame
Assessment of demographic characteristics, clinical signs and symptoms, blood test, urine test, bone marrow test and therapy.	—

Countries

Japan

Contacts

Public ContactMiyuki Tsutsui

Juntendo University Hospital Department of Hematology

tsutsui@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026